Castleview Partners’s MRC Global MRC Stock Holding History

Castleview Partners’s Portfolio MRC Stock Details MRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,975	Closed	-$83K	–	793
2022 Q1	$83K	Buy	+6,975	New	+$65.2K	0.05%	268

Other funds holding MRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

Castleview Partners's MRC Position: Q2 2022 in Review

Castleview Partners sold out of MRC Global (MRC) in Q2 2022, closing a stake of 6,975 shares — an estimated $83K sold.

Castleview Partners first reported a position in MRC in Q1 2022 and held it in 1 quarter. The position peaked at $83K in Q1 2022. 162 funds tracked by Wall St. Rank hold MRC as of Q2 2022.

Castleview Partners reported no remaining MRC Global position as of Q2 2022 after selling out during the quarter.
Castleview Partners sold 6,975 MRC Global shares in Q2 2022, an estimated $83K.
Castleview Partners first reported a position in MRC Global in Q1 2022 and held it in 1 quarter.
Castleview Partners's MRC Global position peaked at $83K in Q1 2022.
162 funds tracked by Wall St. Rank held MRC Global as of Q2 2022.

Based on Castleview Partners's 13F filing for Q2 2022, filed 16 Aug 2022.